UNIPLAN INVESTMENT COUNSEL, INC. Seelos Therapeutics, Inc. Transaction History

UNIPLAN INVESTMENT COUNSEL, INC. portfolio value:

$2.55M
portfolio value

UNIPLAN INVESTMENT COUNSEL, INC. quarter portfolio value change:

+51.40%
quarter

Seelos Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -0.56% -13.88K shares 859K $1.03 2.48M
Q2 2022 share Increase +59.73% 934.60K shares 390K $0.68 2.49M
Q1 2022 share Increase +0.92% 14.24K shares -1.21M $0.84 1.56M
Q4 2021 share Increase +0.27% 4.22K shares -1.19M $1.63 1.55M
Q3 2021 share Decrease -0.22% -3.40K shares -364K $2.41 1.54M
Q2 2021 share Increase +1.34% 20.42K shares -3.54M $2.64 1.54M
Q1 2021 share Decrease -20.65% -397.92K shares 4.58M $4.99 1.52M
Q4 2020 share Decrease -5.21% -105.98K shares 1.14M $1.58 1.92M
Q3 2020 share Increase +49.88% 676.58K shares 534K $0.94 2.03M
Q2 2020 share Decrease -34.44% -712.68K shares 356K $1.01 1.35M
Q1 2020 share Increase +211.39% 1.40M shares 124K $0.49 2.06M
Q4 2019 share Increase +0.91% 6.01K shares 286K $1.34 664.47K
Q3 2019 share Decrease -4.93% -34.16K shares -912K $0.92 658.46K
Q2 2019 share Increase 0.00% 692.62K shares 1.51M $2.19 692.62K